Coronavirus disease 2019 in Latin American patients with multiple sclerosis

Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis and related disorders 2021-10, Vol.55, p.103173-103173, Article 103173
Hauptverfasser:	Fragoso, Yara D., Schiavetti, Irene, Carmisciano, Luca, Ponzano, Marta, Steinberg, Judith, Treviño-Frenk, Irene, Ciampi, Ethel, Vecino, Maria Cecilia A., Correa, Edgar P., Carcamo, Claudia, Gomes, Sidney, Pimentel, Maria Lucia V., Santos, Gutemberg A.C., Vrech, Carlos, Winckler, Thereza C.A., Sormani, Maria Pia
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 Multiple sclerosis ocrelizumab Pandemic rituximab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!